Your browser doesn't support javascript.
loading
Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
Jørgensen, S F; Macpherson, M E; Bjørnetrø, T; Holm, K; Kummen, M; Rashidi, A; Michelsen, A E; Lekva, T; Halvorsen, B; Trøseid, M; Mollnes, T E; Berge, R K; Yndestad, A; Ueland, T; Karlsen, T H; Aukrust, P; Hov, J R; Fevang, B.
Afiliação
  • Jørgensen SF; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway. s.f.jorgensen@medisin.uio.no.
  • Macpherson ME; Section of Clinical Immunology and Infectious Diseases, Department of Rheumatology, Dermatology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Norway. s.f.jorgensen@medisin.uio.no.
  • Bjørnetrø T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. s.f.jorgensen@medisin.uio.no.
  • Holm K; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
  • Kummen M; Section of Clinical Immunology and Infectious Diseases, Department of Rheumatology, Dermatology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Norway.
  • Rashidi A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Michelsen AE; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
  • Lekva T; Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Halvorsen B; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
  • Trøseid M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Mollnes TE; Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Berge RK; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
  • Yndestad A; Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Ueland T; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
  • Karlsen TH; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
  • Aukrust P; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hov JR; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
  • Fevang B; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
Sci Rep ; 14(1): 3704, 2024 Feb 14.
Article em En | MEDLINE | ID: mdl-38355714
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article